<p>A, Apoptotic effect of anticancer drug cisplatin (5–20 μM) in response to antioxidant EGCG (50 μM). B, Apoptotic effect of anticancer drug cisplatin (15 μM) in response to antioxidant PTS (0–10 μM. Error bars represent standard deviations of triplicate experiments.)</p
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>(<b>A</b>) TUNEL staining. Data are presented as mean number of TUNEL-positive cells in each imag...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p>Apoptotic effect of anticancer drug RRx-001 (2.5 μM) in response to antioxidants EGCG (0–50 μM) (...
<p>Asterisk (*) denotes statistical significance (p<0.05) of a signal compared to that from the untr...
<p>A. The structures of B02, doxorubicin, etoposide, topotecan and cisplatin. B. Survival of MDA-MB-...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p>(A-C) MDA-MB-453 cells were treated with the indicated concentration of anti-cancer drugs paclita...
<p>Each LCL experienced lower cisplatin-induced apoptotic activity with the added mithramycin relati...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
<p>A) Annexin V binding by flow cytometry of A549 cells with CLPTM1L knockdown after 48 hours treatm...
<p>(A) Effect of DHT stimulation on cell survival caused by paclitaxel, 5-fluorouracil and cyclophos...
<p>Cytotoxic effect of cisplatin and etoposide on non-sorted cells derived from SCLC cell lines. (A)...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>(<b>A</b>) TUNEL staining. Data are presented as mean number of TUNEL-positive cells in each imag...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p>Apoptotic effect of anticancer drug RRx-001 (2.5 μM) in response to antioxidants EGCG (0–50 μM) (...
<p>Asterisk (*) denotes statistical significance (p<0.05) of a signal compared to that from the untr...
<p>A. The structures of B02, doxorubicin, etoposide, topotecan and cisplatin. B. Survival of MDA-MB-...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p>(A-C) MDA-MB-453 cells were treated with the indicated concentration of anti-cancer drugs paclita...
<p>Each LCL experienced lower cisplatin-induced apoptotic activity with the added mithramycin relati...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p>Cells were pre-treated with 50 µM pan-caspase inhibitor Z-VAD-FMK prior to treatment with 3.2 µM ...
<p>A) Annexin V binding by flow cytometry of A549 cells with CLPTM1L knockdown after 48 hours treatm...
<p>(A) Effect of DHT stimulation on cell survival caused by paclitaxel, 5-fluorouracil and cyclophos...
<p>Cytotoxic effect of cisplatin and etoposide on non-sorted cells derived from SCLC cell lines. (A)...
<p>Cells were treated with MSA, paclitaxel, or the combination for 48 hr, and then subjected to anal...
<p>(<b>A</b>) TUNEL staining. Data are presented as mean number of TUNEL-positive cells in each imag...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
DOI
Add to ORKG